Subscribe To
Clearstar announces appointment of mike pritts as chief executive officer
New CEO brings a wealth of expertise to ClearStar with over 35 years of senior leadership experience in the software and technology sectors. ...
November 3, 2023, 8:50 pm
Clearside biomedical announces presentations at the american academy of ophthalmology 2023 annual meeting
– Clinical Data Utilizing Clearside’s Suprachoroidal Delivery Technology to be Featured in Multiple Oral and Poster Presentations – ...
November 2, 2023, 11:05 am
Clearside biomedical completes recruitment in odyssey phase 2b clinical trial of cls-ax in wet amd
– Successful Completion of Recruitment Driven by Strong Clinical Site Participation and Investigator Support – – Topline Data Expected in Q3 202...
November 1, 2023, 11:05 am
Clearside biomedical to report third quarter 2023 financial results and provide corporate update on monday, november 13, 2023
alpharetta, Ga., Oct. 31, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopha...
October 31, 2023, 11:05 am
Priority technology holdings, inc. announces third quarter 2023 financial results release date and conference call information
alpharetta, Ga.--(BUSINESS WIRE)--Priority Technology Holdings, Inc. (NASDAQ: PRTH) (“Priority” or ...
October 30, 2023, 5:10 pm
Mativ announces conference call to discuss third quarter 2023 results
alpharetta, Ga.--(BUSINESS WIRE)--Mativ Holdings, Inc. (NYSE: MATV) will issue a press release announci...
October 26, 2023, 5:30 pm
Clearside biomedical positive oasis and extension study data presented at the retina society 56th annual scientific meeting
– Excellent Safety Profile, Stable Vision, and Reduced Frequency of Injections Observed for up to 6 months – – ODYSSEY Phase 2b Clinical Trial E...
October 16, 2023, 11:05 am
Aptean reveals 2024 food and beverage industry trends in new report
Automation and Cloud Adoption Drive Profitability in Face of Inflation and Rising Material Prices alpharetta...
October 9, 2023, 8:00 am
Clearside biomedical to participate in panel discussion at the cantor global healthcare conference
alpharetta, Ga., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a bioph...
September 19, 2023, 7:05 am
Avanos medical, inc. to present at the cl king annual best ideas conference
alpharetta, Ga. , Sept. 12, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that...
September 12, 2023, 6:37 am
Clearstar achieves iso 27701:2019 certification for privacy information management system (pims)
Certification Shows ClearStar Meets Rigorous International Standards for Protecting Personal Data alpharetta...
August 28, 2023, 3:15 pm
Avanos medical, inc. to webcast conference call discussing second quarter 2023 financial results
alpharetta, Ga. , Aug. 2, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its confe...
August 2, 2023, 12:31 pm
Clearside biomedical to report second quarter 2023 financial results and provide corporate update on monday, august 14, 2023
alpharetta, Ga., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopha...
August 1, 2023, 7:05 am
Clearside biomedical highlights excellent safety profile of cls-ax and potential for extended duration of effect in data presentation at the american society of retina specialists 41st annual scientif
– Suprachoroidal Injection of CLS-AX Resulted in Favorable Safety Data, Durability and Biologic Effect Over 6 Months – ...
July 31, 2023, 11:05 am
Clearside biomedical highlights excellent safety profile of cls-ax and potential for extended duration of effect in data presentation at the american society of retina specialists 41st annual scientif
– Suprachoroidal Injection of CLS-AX Resulted in Favorable Safety Data, Durability and Biologic Effect Over 6 Months – ...
July 31, 2023, 11:05 am
Clearside biomedical’s suprachoroidal injection platform to be featured at upcoming asrs and ois scientific meetings
– Presentations to Highlight CLS-AX as Promising Wet AMD Treatment with New Mechanism of Action and Potential for Longer Duration of Effect than Cur...
July 20, 2023, 11:05 am
Clearside biomedical opens enrollment in odyssey phase 2b clinical trial of cls-ax (axitinib injectable suspension) in wet amd
– U.S. Clinical Sites Screening Treatment-Experienced Participants with Wet AMD – – ODYSSEY Topline Results Expected in Q3 2024 – ...
June 1, 2023, 11:05 am
Stonebranch mentioned in the 2023 gartner® data and analytics essentials: dataops report
Mentioned as a DataOps Orchestrator, Stonebranch coordinates existing data and analytics tools to provide essential pipeline operations and observabil...
May 30, 2023, 1:11 pm
Verdafresh mdo-pe film qualified by hp as a recyclable barrier substrate for digital print
alpharetta, Ga., May 10, 2023 (GLOBE NEWSWIRE) — HP and Verdafresh have teamed up to qualify that rec...
May 10, 2023, 12:37 pm
Clearside biomedical to participate in a fireside chat at the jmp securities life sciences conference
alpharetta, Ga., May 09, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biophar...
May 9, 2023, 8:30 pm